---
title: "SaniSure"
company_type: Technology Company
headquarters: "United States"
status: "Active"
short_description: "Global leader in designing and manufacturing single-use bioprocessing solutions for pharmaceutical, vaccine, and cell therapy manufacturing."
website: "https://sanisure.com"
founded: "Unknown"
employees: "500+"
primary_focus: ["Single-Use Components", "Bioprocessing Solutions", "Custom Assemblies", "Sterile Manufacturing Systems"]
market_segments: ["Biopharmaceuticals", "Vaccine Manufacturing", "Cell and Gene Therapy", "Advanced Therapeutics"]
publicly_listed: false
date: 2026-02-14
draft: false
---

## Overview

SaniSure is a global leader in designing, developing, and manufacturing single-use solutions for the bioprocessing and advanced therapeutics industries. The company resulted from the merger of six market-leading companies (Cellon, Silicone Altimex, TBL Performance Plastics, Sani-Tech West, GL Engineering, and Medical Elastomer Development) to create a comprehensive single-use solution provider. SaniSure operates five manufacturing facilities globally with extensive capabilities for custom product fabrication.

## Core Products and Solutions

**Single-Use Components**:
- Custom and off-the-shelf assemblies
- Sterile bottles and containers
- Tubing and connectors
- Fittings and connectors
- Mixing and agitation systems
- Filling and transfer systems

**Engineered Systems**:
- Aseptic transfer systems
- Mixing and integration solutions
- Integrated storage systems
- Customized complete assemblies

## Key Capabilities

- **In-House Manufacturing**: Five manufacturing facilities across US and Europe
- **Fully Characterized Components**: All components thoroughly tested and documented
- **Custom Fabrication**: Extensive capability for tailored product development
- **Sterile Systems**: Engineered for sterility assurance and contamination prevention
- **Quality Assurance**: Meets stringent bioprocess requirements

## Industry Applications

- **Biopharmaceutical Manufacturing**: Monoclonal antibodies, recombinant proteins, biosimilars
- **Vaccine Manufacturing**: Single-use systems for vaccine production and filling
- **Cell and Gene Therapy**: Specialized solutions for autologous and allogeneic therapies
- **Advanced Therapeutics**: Emerging therapy manufacturing requirements
- **Research and Development**: Pilot-scale and process development applications

## Strategic Advantages

- **Reduced Contamination Risk**: Single-use eliminates cross-contamination risk
- **Regulatory Compliance**: Designed to meet FDA, EMA, and other regulatory requirements
- **Rapid Implementation**: Single-use systems accelerate time to market
- **Scalability**: Systems designed for seamless scale-up from development to production
- **Cost Efficiency**: Eliminates cleaning validation and related costs

## Market Presence

Global operations with manufacturing facilities in the United States and Europe, serving pharmaceutical, biotech, and advanced therapy companies worldwide.

## Future Vision

SaniSure continues to innovate in single-use technology, developing advanced solutions for emerging manufacturing processes and new therapeutic modalities including gene therapy, cell therapy, and next-generation biologics.

---

*Last updated: 2026-02-14*
